COR vs. EW: Cencora vs. Edwards Lifesciences Stock Comparison
How do Cencora (COR) and Edwards Lifesciences (EW) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Cencora (COR) and Edwards Lifesciences (EW) both fall under the Health Care Equipment & Services industry group, but COR is classified in Health Care Providers & Services while EW is classified in Health Care Equipment & Supplies.
| Profile Item | COR | EW |
|---|---|---|
| Name | Cencora Inc. | Edwards Lifesciences Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Distributors | Health Care Equipment |
| Market Capitalization | 63.65 billion USD | 58.73 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | April 4, 1995 | March 27, 2000 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | COR | EW |
|---|---|---|
| Total Return (1Y) | -3.53% | 25.08% |
| Total Return (3Y, Annualized) | 21.62% | 17.28% |
| Total Return (5Y, Annualized) | 24.10% | -2.77% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | COR | EW |
|---|---|---|
| Volatility (1Y, Annualized) | 31.90% | 25.58% |
| Beta (5Y) | 0.56 | 0.78 |
| Max Drawdown (5Y) | -32.44% | -54.32% |
| Avg. Volume (3M) | 1.29M | 3.69M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | COR | EW |
|---|---|---|
| Sharpe Ratio (1Y) | -0.24 | 0.81 |
| Sortino Ratio (1Y) | -0.30 | 1.23 |
Profitability
ROE (TTM)
Cencora (COR) at 129.01% clears its industry range for ROE, a sharper capital-efficiency signal than Edwards Lifesciences (EW) at 9.33%, which is closer to a typical peer reading.
COR
Health Care Equipment & Services industry group
129.01%
- COR
- 129.01%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
EW
Health Care Equipment & Services industry group
9.33%
- Max
- 47.61%
- Q3
- 14.36%
- EW
- 9.33%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Edwards Lifesciences (EW) at 15.30% retains a top-quartile share of revenue as profit, ahead of Cencora (COR) at 1.03%, which keeps about the industry-typical share.
COR
Health Care Equipment & Services industry group
1.03%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- COR
- 1.03%
- Q1
- -6.29%
- Min
- -28.46%
EW
Health Care Equipment & Services industry group
15.30%
- Max
- 29.35%
- EW
- 15.30%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Edwards Lifesciences (EW) at 30.15% operates in the top operating margin quartile, ahead of Cencora (COR) at 1.27%, which runs around its industry’s norm.
COR
Health Care Equipment & Services industry group
1.27%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- COR
- 1.27%
- Q1
- -0.28%
- Min
- -16.29%
EW
Health Care Equipment & Services industry group
30.15%
- Max
- 35.43%
- EW
- 30.15%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | COR | EW |
|---|---|---|
| ROE (TTM) | 129.01% | 9.33% |
| ROA (TTM) | 3.57% | 8.77% |
| Net Margin (TTM) | 1.03% | 15.30% |
| Operating Margin (TTM) | 1.27% | 30.15% |
| Gross Margin (TTM) | 4.09% | 78.02% |
Growth
Revenue Growth
Only one side can be read here: Edwards Lifesciences (EW) reports revenue growth of 11.55%, ranked against its industry; Cencora (COR) has no revenue growth figure this period.
EPS Growth
Cencora (COR) at 125.50% delivers above-range EPS growth, while Edwards Lifesciences (EW) at -73.74% falls into the bottom quartile — a wide split in earnings momentum.
Growth Metrics
| Metric | COR | EW |
|---|---|---|
| Revenue Growth (YoY) | -- | 11.55% |
| Revenue Growth (3Y CAGR) | -- | 10.77% |
| EPS Growth (YoY) | 125.50% | -73.74% |
| EPS Growth (3Y CAGR) | 28.15% | -9.14% |
Financial Strength
Current Ratio (MRQ)
Edwards Lifesciences (EW) at 4.60 carries current ratio above its industry’s typical mid-range, while Cencora (COR) at 0.94 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.
COR
Health Care Equipment & Services industry group
0.94
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- COR
- 0.94
- Min
- 0.30
EW
Health Care Equipment & Services industry group
4.60
- Max
- 7.59
- EW
- 4.60
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Edwards Lifesciences (EW) at 0.06 keeps leverage in the lower quartile, while Cencora (COR) at 3.06 is above its industry debt-to-equity ratio range.
COR
Health Care Equipment & Services industry group
3.06
- COR
- 3.06
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
EW
Health Care Equipment & Services industry group
0.06
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- EW
- 0.06
- Min
- 0.00
Financial Strength Metrics
| Metric | COR | EW |
|---|---|---|
| Current Ratio (MRQ) | 0.94 | 4.60 |
| Debt / Equity (MRQ) | 3.06 | 0.06 |
| Net Debt / EBITDA | 1.12 | -1.88 |
Dividends
Dividend Yield (TTM)
Edwards Lifesciences (EW) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cencora (COR) reports a yield of 0.71%, ranking against industry peers normally.
COR
Health Care Equipment & Services industry group
0.71%
- COR
- 0.71%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Edwards Lifesciences (EW) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cencora (COR) reports a payout of 17.45%, ranking against industry peers normally.
COR
Health Care Equipment & Services industry group
17.45%
- COR
- 17.45%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | COR | EW |
|---|---|---|
| Dividend Yield (TTM) | 0.71% | 0.00% |
| Dividend Payout Ratio (TTM) | 17.45% | 0.00% |
Valuation
P/E Ratio (TTM)
Cencora (COR) at 18.58 sits in the cheaper P/E ratio quartile, while Edwards Lifesciences (EW) at 59.38 sits in the richer quartile — a clear split in what investors pay for each dollar of trailing earnings.
COR
Health Care Equipment & Services industry group
18.58
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- COR
- 18.58
- Min
- 4.21
EW
Health Care Equipment & Services industry group
59.38
- Max
- 80.41
- EW
- 59.38
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Cencora (COR) at 0.19 looks cheap on sales in the lower P/S ratio quartile, while Edwards Lifesciences (EW) at 8.80 looks rich in the upper quartile — a clear gap in price per dollar of revenue.
COR
Health Care Equipment & Services industry group
0.19
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- COR
- 0.19
- Min
- 0.03
EW
Health Care Equipment & Services industry group
8.80
- EW
- 8.80
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Edwards Lifesciences (EW) at 5.41 sits near its industry’s typical P/B ratio, while Cencora (COR) at 17.29 prices above its benchmark range — COR looks rich relative to book.
COR
Health Care Equipment & Services industry group
17.29
- COR
- 17.29
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
EW
Health Care Equipment & Services industry group
5.41
- Max
- 11.68
- Q3
- 6.12
- EW
- 5.41
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | COR | EW |
|---|---|---|
| P/E Ratio (TTM) | 18.58 | 59.38 |
| P/S Ratio (TTM) | 0.19 | 8.80 |
| P/B Ratio (MRQ) | 17.29 | 5.41 |
| Free Cash Flow Yield (TTM) | 2.81% | 1.95% |